Electronic prior authorization (EPA) technology can streamline the complex process of obtaining prior authorizations for GLP-1 medications.
Mike Cohn
Advertisement
Articles by Mike Cohn
The expert explored the complex prior authorization process for GLP-1 medications, discussing challenges in documentation and medical necessity.
Advertisement
Latest Updated Articles
Navigating GLP-1 Medications: Prior Authorization Challenges and SolutionsPublished: May 27th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Zuranolone Offers New Hope for Postpartum Depression
3
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
4
Updated Hypertension Guidelines Are Here
5
